Cleared Traditional

K142153 - HUDSON RCI ADDIPAK UNIT DOSE VIAL, 0.9% FULL NORMAL SALINE SOLUTION, 3ML (FDA 510(k) Clearance)

Also includes:
5ML 15ML
Apr 2015
Decision
266d
Days
Class 2
Risk

K142153 is an FDA 510(k) clearance for the HUDSON RCI ADDIPAK UNIT DOSE VIAL, 0.9% FULL NORMAL SALINE SOLUTION, 3ML. This device is classified as a Nebulizer (direct Patient Interface) (Class II - Special Controls, product code CAF).

Submitted by Teleflexmedical, Inc. (Durham, US). The FDA issued a Cleared decision on April 29, 2015, 266 days after receiving the submission on August 6, 2014.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5630.

Submission Details

510(k) Number K142153 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2014
Decision Date April 29, 2015
Days to Decision 266 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code CAF — Nebulizer (direct Patient Interface)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.5630